FSD Pharma (NASDAQ:HUGE) Stock Price Up 4.8%

FSD Pharma Inc. (NASDAQ:HUGE) rose 4.8% during mid-day trading on Monday . The stock traded as high as $0.53 and last traded at $0.49. Approximately 675,003 shares traded hands during trading, an increase of 398% from the average daily volume of 135,425 shares. The stock had previously closed at $0.47.

FSD Pharma Stock Performance

The stock has a market cap of $19.26 million, a price-to-earnings ratio of -1.04 and a beta of 0.59. The business’s 50 day moving average is $0.74 and its 200 day moving average is $0.91.

FSD Pharma (NASDAQ:HUGE) last announced its quarterly earnings data on Thursday, March 28th. The company reported ($0.04) earnings per share (EPS) for the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in FSD Pharma stock. Scotia Capital Inc. bought a new position in shares of FSD Pharma Inc. (NASDAQ:HUGE) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 61,273 shares of the company’s stock, valued at approximately $55,000. Scotia Capital Inc. owned about 0.16% of FSD Pharma at the end of the most recent reporting period. Hedge funds and other institutional investors own 1.24% of the company’s stock.

FSD Pharma Company Profile

FSD Pharma Inc, a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders.